Human Investing’s Chemours CC Stock Holding History

Human Investing’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-81	Closed	-$2K	–	127
2021 Q1	$2K	Hold	81	–	–	﹤0.01%	276
2020 Q4	$2K	Hold	81	–	–	﹤0.01%	275
2020 Q3	$2K	Hold	81	–	–	﹤0.01%	274
2020 Q2	$1K	Hold	81	–	–	﹤0.01%	295
2020 Q1	$1K	Hold	81	–	–	﹤0.01%	287
2019 Q4	$1K	Hold	81	–	–	﹤0.01%	350
2019 Q3	$1K	Hold	81	–	–	﹤0.01%	337
2019 Q2	$2K	Sell	81 -82	-50%	-$2.42K	﹤0.01%	324
2019 Q1	$6K	Sell	163 -2,708	-94%	-$98.5K	﹤0.01%	276
2018 Q4	$81K	Buy	+2,871	New	+$90.8K	0.03%	174

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Human Investing's CC Position: Q2 2021 in Review

Human Investing sold out of Chemours (CC) in Q2 2021, closing a stake of 81 shares — an estimated $2K sold.

Human Investing first reported a position in CC in Q4 2018 and held it in 10 quarters. The position peaked at $81K in Q4 2018. 449 funds tracked by Wall St. Rank hold CC as of Q2 2021.

Human Investing reported no remaining Chemours position as of Q2 2021 after selling out during the quarter.
Human Investing sold 81 Chemours shares in Q2 2021, an estimated $2K.
Human Investing first reported a position in Chemours in Q4 2018 and held it in 10 quarters.
Human Investing's Chemours position peaked at $81K in Q4 2018.
449 funds tracked by Wall St. Rank held Chemours as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.